Join us for a discussion on regulatory developments relating to clinical trials in the Life Sciences sector. Topics include:

  • Changes to the Regulatory Landscape for Clinical Trials
  • Ensuring Diversity in Clinical Trials
  • Conducting Clinical Trials Remotely
  • Additional Challenges for Rare Disease Clinical Trials
  • Ensuring Compliance and Data Integrity
  • How Clinical Trials affect Representations and Warranties in M&A and Investment Deals
  • IPO preparedness for companies with clinical trials

CLE is not available when viewing a recording of this program. In order to receive credit you must have attended the live webinar program.

Downloads –